Medical Device News Magazine

Northwell Releases AI-driven Pregnancy Chatbot, Providing Virtual Safety Net to Protect Pregnant Women

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Northwell Health today announced the rollout of Northwell Health Pregnancy Chats to obstetrics practices throughout the health system. An artificial intelligence-driven pregnancy chatbot, the customized, conversational platform is a key tool in Northwell’s high-tech and high-touch campaign to reduce maternal morbidity and mortality. The United States has the highest rates of those problems of any of the world’s industrialized nations.

The pregnancy chatbot is both an educational program and a virtual safety net that can identify urgent concerns and ensure speedy help for women during and after pregnancy. It offers weekly informational dialogs that are based on the stage of pregnancy and personalized according to a patient’s self-reported risk factors. Many of the chat’s questions are designed to help patients notice subtle changes sooner than they otherwise might have, which can lead to earlier detection if complications are developing.

The chatbot links seamlessly with a Northwell care management team, enabling prompt escalation to in-person clinical care if a patient’s responses indicate a potentially serious issue, generally directing the patient to connect with her provider. “Red flag” responses trigger an immediate call from a care navigator at Northwell Health Solutions, the health system’s care management arm — or, in some cases, instructions to call 911 or go to the nearest emergency department.

A pilot program at a Northwell obstetric practice showed the tool to be effective. The chatbot was used by 1,632 patients, 96% of whom reported being satisfied or somewhat satisfied with the experience. Critically, the chatbot successfully identified urgent health problems in a handful of users. One woman whose red-flag responses regarding blood pressure prompted a message to call 911 was found to have severe preeclampsia requiring hospitalization. (Preeclampsia is a serious condition involving high blood pressure during pregnancy and can be fatal if not treated.) In another case, during an automated new-parent chat, a woman shared that she had experienced thoughts of harming herself; she reported that she had not shared her symptoms with her provider but felt comfortable acknowledging them to the chatbot because of the feeling of anonymity. The care team reached out immediately and within 24 hours was able to connect the patient with a psychiatrist and other mental health support.

“Northwell Health Pregnancy Chats are both extremely comprehensive and highly individualized and are designed to complement the interactions patients have with their providers,” said Michael Nimaroff, MD, senior vice president of Northwell’s OB/GYN service line and chair of Obstetrics and Gynecology for North Shore University Hospital and Long Island Jewish Medical Center. “It’s a way to ensure women are never without support, whether they’re in a doctor’s office or in their own home.”

The Northwell Health Pregnancy Chats were developed in conjunction with Conversa Health (part of Amwell), a leader in providing automated virtual health. Spanning pregnancy and the first year postpartum, the chats include a health risk assessment and cover maternal and fetal changes throughout pregnancy, blood pressure tracking, prenatal testing, birth plans, lactation support and more. The chatbot will eventually be offered to women receiving pregnancy care at clinics and OB practices throughout Northwell’s catchment area. Sign-up is at no cost to the patient, and chats can be accessed on a patient’s smartphone, tablet or computer.

The tool is an important step in Northwell’s initiative to reduce the country’s maternal mortality rate. In the U.S., 26 out of 100,000 women die during childbirth, compared to 4 out of 100,000 in Italy and Denmark and 9 out of 100,000 in the United Kingdom. The risk is particularly extreme for Black women in the U.S., who are three times more likely than white women to die from pregnancy-related causes. Last year, Northwell launched its Center for Maternal Health to address these risks through a multitude of programs, focusing both on hospital care and community-based wellness efforts.

“Far too many pregnant and birthing people in this country suffer harm or even die because of problems that are entirely preventable. Northwell is committed to doing whatever is necessary to reduce those risks,” said Dawnette Lewis, MD, MPH, director of the Center for Maternal Health. “By bringing together high-tech innovation and high-touch clinical care, the Northwell Health Pregnancy Chats will help keep women and babies safe.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”